Gilead Sciences Inc (GILD)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$124.65

Buy

$126.00

arrow-down$-0.28 (-0.22%)

Prices updated at 13 Jun 2026, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovald ...
NASDAQ
arrow-up0.31%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.

Most recent dividend payment

0.820
Cash Dividend
15 Jun 2026
07 May 2026
15 Jun 2026
29 Jun 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20261.6400-
20253.16000.03
20243.08000.03
20233.00000.03
20222.92000.03
20212.84000.04
20202.72000.08
20192.52000.11
20182.28000.10
20172.08000.13

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20262.440.93
20252.570.98
20243.330.59
20233.701.25
20223.400.47
20213.910.36
20204.671.93
20193.882.89
20183.652.19
20172.901.75

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20261.6400
20253.1600
20243.0800
20233.0000
20222.9200
20212.8400
20202.7200
20192.5200
20182.2800
20172.0800

% of earnings paid to shareholders data table

YearPayout ratio (%)
202646.61
202548.61
20243,400.00
202363.81
2022109.85
202147.87
2020272.45
2019116.04
2018182.79
201723.09
Latest Financial Report as of 11 Jun 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.